UTSMC researchers made nanoparticle vaccine that targets multiple cancer types in mice, exploring possibility of testing on human patients

Briefing

UTSMC researchers made nanoparticle vaccine that targets multiple cancer types in mice, exploring possibility of testing on human patients

April 27, 2017

Briefing
  • Nanoparticle Vaccine – University of Texas Southwestern Medical Center made nanoparticle vaccine that can target different cancer types in miceNanoparticle Vaccine – University of Texas Southwestern Medical Center made nanoparticle vaccine that can target different cancer types in mice
  • How It Works – Vaccine activates protein, called stimulator of interferon genes (STING), which stimulates body’s immune system to fight cancer
  • Positive Study Results – Slowed tumor growth and prolonged life span of mice with different forms of cancer, such as melanoma, colon, cervix, head, neck, and anogenital cancers
  • Clinical Trials – Exploring starting clinical testing on human patients with various cancers

Accelerator
Biotechnology and Bioinformatics

Sector
Healthcare/Health Sciences

Organization
University of Texas Southwestern Medical Center

Source

Original Publication Date
April 24, 2017

Leave a comment